These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2576320

  • 1. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D, Dixon K, Enz A, Shearman G, Urwyler S, White T, Karobath M.
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [Abstract] [Full Text] [Related]

  • 2. Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912.
    Coward DM, Dixon AK, Urwyler S, White TG, Enz A, Karobath M, Shearman G.
    J Pharmacol Exp Ther; 1990 Jan; 252(1):279-85. PubMed ID: 1967646
    [Abstract] [Full Text] [Related]

  • 3. [Dopanergic agonists and schizophrenia].
    Pidgeon JF, Wolf MA.
    Psychiatr J Univ Ott; 1989 Nov; 14(4):529-35. PubMed ID: 2573101
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression.
    Benkert O, Gründer G, Wetzel H.
    Pharmacopsychiatry; 1992 Nov; 25(6):254-60. PubMed ID: 1362997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT.
    Turk Psikiyatri Derg; 2009 Nov; 20(2):175-82. PubMed ID: 19504368
    [Abstract] [Full Text] [Related]

  • 16. New perspectives on biological treatment of schizophrenia.
    Lingjaerde O.
    Acta Psychiatr Scand Suppl; 1994 Nov; 384():102-7. PubMed ID: 7879631
    [Abstract] [Full Text] [Related]

  • 17. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK, Jeong D, Cho H, Lee SJ, Cha MY, Pae AN, Choi KI, Koh HY, Kong JY.
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.